This is a Validated Antibody Database (VAD) review about human RAP2A, based on 4 published articles (read how Labome selects the articles), using RAP2A antibody in all methods. It is aimed to help Labome visitors find the most suited RAP2A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
RAP2A synonym: K-REV; KREV; RAP2; RbBP-30; ras-related protein Rap-2a; RAP2, member of RAS oncogene family (K-rev)
Novus Biologicals
rabbit polyclonal |
| Novus Biologicals RAP2A antibody (Novus Biologicals, NBP2-24574) was used in immunohistochemistry on human samples at 1:250 (fig 2). Am J Transl Res (2015) ncbi |
BD Biosciences
mouse monoclonal (12/Rap2) |
| BD Biosciences RAP2A antibody (BD Biosciences, 610215) was used in western blot on rat samples at 1:2000 (fig 1d). Neuron (2018) ncbi |
mouse monoclonal (12/Rap2) |
| In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences RAP2A antibody (BD, 12) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi |
mouse monoclonal (12/Rap2) |
| In order to study the dysregulation of Rap2 activity due to PSD-Zip70 deficiency that causes prefrontal hypofunction associated with glutamatergic synapse maturation defects, BD Biosciences RAP2A antibody (BD Transduction Laboratories, 610216) was used in western blot on mouse samples (fig 4). J Neurosci (2015) ncbi |
Articles Reviewed
- Lee Y, He H, Chen T, Lee S, Chang I, Hsing C, et al. The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area. Am J Transl Res. 2015;7:912-21 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments